Cargando…
Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene
BACKGROUND: Genetic diversity of mutations in the CYP21A2 gene is the main cause of the monogenic congenital adrenal hyperplasia (CAH) disorder. On chromosome 6p21.3, the CYP21A2 gene is partially overlapped by the TNXB gene, the two residing in tandem with their highly homologous corresponding pseu...
Autores principales: | Fanis, Pavlos, Skordis, Nicos, Phylactou, Leonidas A., Neocleous, Vassos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011304/ https://www.ncbi.nlm.nih.gov/pubmed/36264454 http://dx.doi.org/10.1007/s42000-022-00410-w |
Ejemplares similares
-
Genotype Is Associated to the Degree of Virilization in Patients With Classic Congenital Adrenal Hyperplasia
por: Neocleous, Vassos, et al.
Publicado: (2018) -
The pathogenic p.Gln319Ter variant is not causing congenital adrenal hyperplasia when inherited in one of the duplicated CYP21A2 genes
por: Fanis, Pavlos, et al.
Publicado: (2023) -
RET Proto-Oncogene Variants in Patients with Medullary Thyroid Carcinoma from the Mediterranean Basin: A Brief Report
por: Neocleous, Vassos, et al.
Publicado: (2023) -
Gonadotropin-Releasing Hormone Receptor (GnRHR) and Hypogonadotropic Hypogonadism
por: Fanis, Pavlos, et al.
Publicado: (2023) -
Phenotypic variability of hyperandrogenemia in females heterozygous for CYP21A2 mutations
por: Neocleous, Vassos, et al.
Publicado: (2014)